Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Effects of concurrent treatment with amitriptyline hydrochloride tablets and fluoxetine hydrochloride on therapeutic indicator levels in patients with depression

Yin Jie¹ , Deng Shuang², Zhan Xinjie³

¹Department of Psychology, Nanjing Institute of Politics, Nanjing City; ²College of Life Sciences, Hunan University of Science and Technology, Xiangtan City; ³Department of Clinical Laboratory, Ningxiang Peopleâ€™s Hospital, Ningxiang City, China.

For correspondence:- Yin Jie Email: rj1187@163.com

Accepted: 17 January 2019 Published: 28 February 2019

Citation: Jie Y, Shuang D, Xinjie Z. Effects of concurrent treatment with amitriptyline hydrochloride tablets and fluoxetine hydrochloride on therapeutic indicator levels in patients with depression. Trop J Pharm Res 2019; 18(2):403-408 doi: 10.4314/tjpr.v18i2.26

© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effects of combined treatment of amitriptyline hydrochloride tablets and fluoxetine hydrochloride on therapeutic indicator levels in depressive patients.

Methods: Patients with depression (n = 104) were divided into control group and study group (52 cases each) using random number table method. Control group was treated with oral fluoxetine hydrochloride (FH) tablets only, while the study group received amitriptyline hydrochloride tablets, in addition to fluoxetine hydrochloride tablets. Both treatments lasted 3 months. Clinical effects and thyroid function indices were determined and compared for the two groups.

Results: Treatment effectiveness in the study group (92.3 %) was markedly higher than that in control group (75.0 %, p < 0.05). In both groups, Pittsburgh Sleep Quality Index, Hamilton Depression Scale and Hamilton Anxiety Table scores significantly decreased post-treatment (p < 0.05). In contrast, there was significant increase in γ-aminobutyric acid (GABA) and serotonin (5-HT) levels in the two groups. In both groups, T3 and T4 significantly decreased while thyroid stimulating hormone (TSH) increased significantly (p < 0.05). Thyroid function in the study group was markedly higher than in the control group (p < 0.05).

Conclusion: Combination treatment with amitriptyline hydrochloride tablets and FH is more effective than FH alone in the treatment of patients with depression. The combined treatment has a high degree of safety and is recommended for clinical application.

Keywords: Amitriptyline hydrochloride, Fluoxetine hydrochloride, Depression, PSQI score, HAMD-17 score, HAMA score, GABA, 5-HT